Adynovate 2000 Unit (Antihemophilic Factor (Recombinant), Pegylated KIT) 2000 UNIT

ADYNOVATE 2000 Unit is a recombinant, pegylated antihemophilic factor used for hemophilia B treatment. This intravenous kit helps manage bleeding episodes and prevent complications.

Strength

2000 UNIT

Pack Size

5ML

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADYNOVATE 2000 Unit is primarily used to control and prevent bleeding in individuals with hemophilia B, a condition characterized by reduced clotting ability. It works by replacing the missing clotting factor, helping to form blood clots and stop bleeding. This medication is often used for on-demand treatment of bleeding episodes and can also be used for routine prophylaxis to prevent bleeding.

Side Effects

Common effects of ADYNOVATE 2000 Unit may include mild reactions at the injection site, such as redness or swelling. Some users might experience headache, nausea, or dizziness. Severe allergic reactions are rare but possible. Always consult a healthcare provider if you experience any unusual symptoms.

Precautions & Warnings

ADYNOVATE 2000 Unit should be handled with care, following proper sterile techniques for intravenous administration. Store the kit as directed, typically in a refrigerator, to maintain its efficacy. Do not use if the solution appears discolored or contains particles. Always follow the instructions provided by your healthcare provider.

Avoid Interactions

ADYNOVATE 2000 Unit may interact with certain medications, including those that affect blood clotting. Always inform your healthcare provider about all medications you are taking. Avoid using other blood-thinning medications unless directed by a healthcare professional. Alcohol consumption should be moderated, as it can affect clotting ability.

Frequently Asked Questions

ADYNOVATE 2000 Unit is used to control and prevent bleeding in individuals with hemophilia B.

ADYNOVATE 2000 Unit is administered intravenously, typically by a healthcare professional or trained individual.

Common side effects may include mild reactions at the injection site, headache, nausea, or dizziness.

Yes, ADYNOVATE 2000 Unit can be used for routine prophylaxis to prevent bleeding episodes in individuals with hemophilia B.

ADYNOVATE 2000 Unit should be stored in a refrigerator, following the specific storage instructions provided.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.